BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 31121496)

  • 1. Cytokine expression profiles in cervical mucus from patients with cervical cancer and its precursor lesions.
    Otani S; Fujii T; Kukimoto I; Yamamoto N; Tsukamoto T; Ichikawa R; Nishio E; Iwata A
    Cytokine; 2019 Aug; 120():210-219. PubMed ID: 31121496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor.
    Hubert P; van den Brüle F; Giannini SL; Franzen-Detrooz E; Boniver J; Delvenne P
    Am J Pathol; 1999 Mar; 154(3):775-84. PubMed ID: 10079255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus.
    Cotrim ACM; França EL; Martins JS; Silva KPG; Fujimori M; Ghalfi YC; Machado IT; Honorio-França AC; Tozetti IA
    Cancer Immunol Immunother; 2021 Sep; 70(9):2721-2726. PubMed ID: 33797568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Cervical Inflammatory Mediators and Prevalent Cervical Human Papillomavirus Infection.
    Olukomogbon T; Akpobome B; Omole A; ; Adebamowo CA; Adebamowo SN
    JCO Glob Oncol; 2024 Mar; 10():e2300380. PubMed ID: 38547441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.
    Castle PE; Phillips TM; Hildesheim A; Herrero R; Bratti MC; Rodríguez AC; Morera LA; Pfeiffer R; Hutchinson ML; Pinto LA; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1449-56. PubMed ID: 14693736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cytokine levels and human papillomavirus infection at the cervix in rural Nigerian women.
    Mbulaiteye SM; Kemp T; Gage JC; Ajenifuja KO; Kiruthu C; Wentzensen NA; Adepiti C; Wacholder S; Burk RD; Schiffman M; Pinto L
    Cytokine; 2013 Oct; 64(1):146-51. PubMed ID: 23972725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex determination of murine seminal fluid cytokine profiles.
    Gopichandran N; Ekbote UV; Walker JJ; Brooke D; Orsi NM
    Reproduction; 2006 Mar; 131(3):613-21. PubMed ID: 16514204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytokine status of cervical mucus in women with transitory and persistent course of papillomavirus infection].
    Telesheva LF; Dolgushina VF; Abramovskikh OS; Zotova MA; Mezentseva EA; Orner IIu; Baturina IL; Akhmatova AN
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (4):118-21. PubMed ID: 22937720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.
    Fujii T; Nishio E; Tsukamoto T; Kukimoto I; Iwata A
    Cancer Sci; 2024 May; ():. PubMed ID: 38749770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women.
    Marks MA; Viscidi RP; Chang K; Silver M; Burke A; Howard R; Gravitt PE
    Cytokine; 2011 Dec; 56(3):798-803. PubMed ID: 22015106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine and serum cytokine arrays in the mouse during estrus.
    Orsi NM; Ekbote UV; Walker JJ; Gopichandran N
    Anim Reprod Sci; 2007 Aug; 100(3-4):301-10. PubMed ID: 16963201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins.
    Sahin E; Madendag Y; Sahin ME; Madendag IC; Acmaz G; Karakukcu C; Karaman H; Muderris II
    Cancer Control; 2018; 25(1):1073274818798598. PubMed ID: 30180755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection.
    Kemp TJ; Hildesheim A; García-Piñeres A; Williams MC; Shearer GM; Rodriguez AC; Schiffman M; Burk R; Freer E; Bonilla J; Herrero R; Pinto LA
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1954-9. PubMed ID: 20647411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
    Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
    Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
    Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
    Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
    J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix.
    de Gruijl TD; Bontkes HJ; van den Muysenberg AJ; van Oostveen JW; Stukart MJ; Verheijen RH; van der Vange N; Snijders PJ; Meijer CJ; Walboomers JM; Scheper RJ
    Eur J Cancer; 1999 Mar; 35(3):490-7. PubMed ID: 10448305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical mucus granulocyte macrophage colony stimulating factor and interleukin-2 soluble receptor in women using copper intrauterine contraceptive devices.
    Shobokshi A; Shaarawy M
    Contraception; 2002 Aug; 66(2):129-32. PubMed ID: 12204787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
    BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.